Telehealth company Hims & Hers Health Inc. said late Monday it is in “active discussions” with Denmark’s Novo Nordisk A/S to ...
The latest buyout Novo Nordisk is trying to pull off is putting it in a direct confrontation with another beaten-down ...
Neurocrine Biosciences has penned a deal with China’s TransThera Sciences potentially worth more than $880 million in ...
Competition is heating up, but questions remain about insurance coverage, drug pricing, copycat drugs and the role of pills in the space.
Despite success with injectable drugs pharma companies are investing heavily in tablets, long considered the holy grail of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback